DalCor Pharmaceuticals   Report issue

For profit Phase 3
Founded: Montreal Canada (2015)

Organization Overview

First Clinical Trial
2016
NCT02525939
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

DalCor Pharmaceuticals